Evernest Financial Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Buy
2,428
+300
+14% +$26.7K 0.04% 173
2025
Q4
$200K Sell
2,128
-1,417
-40% -$111K 0.04% 176
2025
Q3
$283K Sell
3,545
-151
-4% -$12.9K 0.08% 155
2025
Q2
$336K Buy
3,696
+727
+24% +$66.4K 0.11% 132
2025
Q1
$278K Buy
2,969
+277
+10% +$24.8K 0.1% 132
2024
Q4
$245K Sell
2,692
-68
-2% -$6.49K 0.06% 144
2024
Q3
$286K Sell
2,760
-225
-8% -$22.9K 0.08% 132
2024
Q2
$290K Buy
2,985
+115
+4% +$10.6K 0.13% 110
2024
Q1
$250K Sell
2,870
-185
-6% -$15.7K 0.12% 115
2023
Q4
$244K Buy
+3,055
New +$230K 0.12% 116
2021
Q4
$239K Buy
+2,861
New +$223K 0.12% 111

Other funds holding CL

Evernest Financial Advisors's CL Position: Q1 2026 in Review

Evernest Financial Advisors increased its Colgate-Palmolive (CL) stake by 14% in Q1 2026, buying an estimated $26.7K and bringing the position to 2,428 shares worth $204K. The position accounts for 0.04% of the portfolio, ranked #173.

Evernest Financial Advisors first reported a position in CL in Q4 2021 and has held it in 11 quarters since. The position peaked at $336K in Q2 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Evernest Financial Advisors held 2,428 shares of Colgate-Palmolive worth $204K as of Q1 2026.
  • Evernest Financial Advisors bought 300 Colgate-Palmolive shares in Q1 2026, an estimated $26.7K.
  • Colgate-Palmolive made up 0.04% of Evernest Financial Advisors's portfolio in Q1 2026, its #173 holding.
  • Evernest Financial Advisors first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 11 quarters since.
  • Evernest Financial Advisors's Colgate-Palmolive position peaked at $336K in Q2 2025.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Evernest Financial Advisors's 13F filing for Q1 2026, filed 4 May 2026.